title: Treatment and Prognosis of Pulmonary Hypertension in the Left Ventricular Assist Device Patient.
abstract: This review will discuss the medical management of pulmonary hypertension in patients with left ventricular assist devices. Although much has been written on the management of primary pulmonary hypertension, also called pulmonary arterial hypertension, this review will instead focus on the treatment of pulmonary hypertension secondary to left heart disease. The relevant pharmacotherapy can be divided into medications for treating heart failure, such as diuretics and β-blockers, and medications for treating pulmonary hypertension. We also discuss important preoperative considerations in patients with pulmonary hypertension; the relationships between left ventricular assist devices, pulmonary hemodynamics, and right heart failure; as well as optimal perioperative and long-term postoperative medical management of pulmonary hypertension.
authors.affiliation: Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: Christopher W
authors.initials: CW
authors.lastname: Jensen
authors.affiliation: Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: Andrew B
authors.initials: AB
authors.lastname: Goldstone
authors.affiliation: Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, CA, USA. joswoo@stanford.edu.|Department of Bioengineering, Stanford University, Falk Building CV-235, 300 Pasteur Drive, Stanford, CA, 94305-5407, USA. joswoo@stanford.edu.
authors.forename: Y Joseph
authors.initials: YJ
authors.lastname: Woo
mesh_terms: D006333:Heart Failure / Q000150:complications* / Q000628:therapy*; D006353:Heart-Assist Devices; D006439:Hemodynamics; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology*; D011379:Prognosis; D018497:Ventricular Dysfunction, Right / Q000150:complications
keywords: Bosentan; Left heart failure; Nitric oxide; Pulmonary hypertension; Sildenafil; Ventricular assist device